Ex Parte Wang - Page 4




              Appeal No. 2006-0293                                                                                       
              Application No. 10/071,809                                                                                 


              col. 8, ll. 5-7, with Figure 5).  It is clear from Figure 5 of Tsai that the selectivity                   
              decreases when the oxygen flow rate is increased from 0 to 10 sccm, although the                           
              selectivity increases at a constant oxygen flow rate when the flow rate of nitrogen                        
              increases.  It is also clear from Figure 4 of Tsai that, at any nitrogen flow rate, the                    
              polysilicon etching rate undesirably increases with increasing oxygen flow rates from 0                    
              to 10 sccm.                                                                                                
                     Additionally, as correctly argued by appellant (Brief, page 6), Tsai teaches away                   
              from the use of “excessively high” flow rates of oxygen (Tsai, col. 7, ll. 15-20).                         
              Furthermore, Tsai teaches preferred volume flow ratios where the maximum volume                            
              flow of oxygen could be 13.89% (col. 8, ll. 17-22, where the oxygen/nitrogen ratio is 5:1                  
              and the chlorine to oxygen+nitrogen ratio is 5:1).  Finally, Tsai exemplifies about a 3%                   
              by volume oxygen plasma gas to achieve a selectivity of about 4-5 (col. 9, ll. 23-45).                     
                     “Under the proper legal standard, a reference will teach away when it suggests                      
              that the developments flowing from its disclosures are unlikely to produce the objective                   
              of the applicant’s invention.  In re Gurley, 27 F.3d 551, 553 (Fed. Cir. 1994).”  Syntex v.                
              Apotex, 407 F.3d 1371, 1380, 74 USPQ2d 1823, 1830 (Fed. Cir. 2005).  General                               
              skepticism of those in the art is relevant and persuasive evidence of non-obviousness.                     
              See Gillette Co. v. S.C. Johnson & Son, Inc., 919 F.2d 720, 726, 16 USPQ2d 1923,                           
              1929 (Fed. Cir. 1990).  The disclosures of Tsai, as discussed above and in the Brief,                      
              certainly suggests developments that are unlikely to produce the objective of appellant’s                  

                                                           4                                                             





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007